Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Nov 24, 2022; 13(11): 918-928
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.918
Table 1 Tumor features on magnetic resonance imaging

Total
MVI group
Non-MVI group
P value
Tumors, n (%)50 (100)15 (30)35 (70)
Size (mm), mean (SD)56.4 (34.6)41.3 (29.1)0.107
Multiplicity, n (%)0.087
Single43 (86)15 (100)28 (80)
Multifocal7 (14)07 (20)
T1 (unenhanced), n (%)0.346
Hypointense46 (92)13 (87)33 (94)
Isointense2 (4)1 (7)1 (3)
Hyperintense2 (4)1 (7)1 (3)
T1 (arterial phase), n (%)0.663
Hypointense6 (12)1 (7)5 (14)
Isointense6 (12)1 (7)5 (14)
Hyperintense38 (76)13 (87)25 (71)
T1 (portal venous phase), n (%)0.231
Hypointense42 (84)14 (93)28 (80)
Isointense6 (12)0 (0)6 (17)
Hyperintense2 (4)1 (7)1 (3)
T1 (equilibrium phase), n (%)0.654
Hypointense45 (90)14 (93)31 (89)
Isointense4 (8)1 (7)3 (9)
Hyperintense00 (0)0 (0)
T1 (HPB phase), n (%)0.664
Hypointense33 (66)9 (60)24 (69)
Isointense1 (2)01 (3)
Not performed16 (32)6 (40)10 (28)
T2 hyperintensity, n (%)0.451
Present42 (84)12 (80)30 (86)
Absent8 (16)3 (20)5 (14)
Restricted diffusion, n (%)0.745
Present44 (88)13 (87)31 (89)
Absent5 (10)2 (13)3 (9)
Not performed1 (2)0 (0)1 (3)
Visible vessels (arterial phase), n (%)0.001
Present11 (22)8 (53)3 (9)
Absent39 (78)7 (47)32 (91)
Visible vessels (portal venous phase), n (%)0.043
Present8 (16)5 (33)3 (9)
Absent42 (84)10 (67)32 (91)
Peritumoral enhancement, n (%)0.248
Present15 (30)6 (40)9 (26)
Absent35 (70)9 (60)26 (74)
Hypodense halo, n (%)0.524
Present5 (10)1 (7)4 (11)
Absent45 (90)14 (93)31 (89)
Border between tumour and liver, n (%)0.428
Sharp34 (68)11 (73)23 (66)
Ill-defined16 (32)4 (27)12 (34)
Tumor margins, n (%)0.477
Smooth28 (56)9 (60)19 (54)
Non-smooth22 (44)6 (40)16 (46)
LI-RADS, n (%)0.05
LR-410 (20)0 (0)10 (29)
LR-527 (54)10 (67)17 (49)
LR-M13 (26)5 (33)8 (22)